,MeSH Unique ID,MeSH Heading,ScopeNote,MeSHBrowserLink
0,D008659,Metabolic Diseases,"Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)",https://meshb.nlm.nih.gov/record/ui?ui=D008659
1,D013312,"Stress, Physiological","The unfavorable effect of environmental factors (stressors) on the physiological functions of an organism. Prolonged unresolved physiological stress can affect HOMEOSTASIS of the organism, and may lead to damaging or pathological conditions.",https://meshb.nlm.nih.gov/record/ui?ui=D013312
2,D024821,Metabolic Syndrome,A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.,https://meshb.nlm.nih.gov/record/ui?ui=D024821
3,D008660,Metabolism,The chemical reactions in living organisms by which energy is provided for vital processes and activities and new material is assimilated.,https://meshb.nlm.nih.gov/record/ui?ui=D008660
4,D065767,"Activation, Metabolic",The conversion of an exogenous substance by a biological system resulting in the production on an active metabolite.,https://meshb.nlm.nih.gov/record/ui?ui=D065767
5,D015431,Weight Loss,Decrease in existing BODY WEIGHT.,https://meshb.nlm.nih.gov/record/ui?ui=D015431
6,D011634,Public Health,"Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level.",https://meshb.nlm.nih.gov/record/ui?ui=D011634
7,D009765,Obesity,"A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).",https://meshb.nlm.nih.gov/record/ui?ui=D009765
8,D056128,"Obesity, Abdominal",Obesity due to excessive deposition of INTRA-ABDOMINAL FAT in the abdominal VISCERA and OMENTUM.,https://meshb.nlm.nih.gov/record/ui?ui=D056128
9,D000079322,Weight Prejudice,Negative attitudes towards and beliefs about others because of their weight. These negative attitudes are manifested by stereotypes and/or prejudice towards people with weight over or under a cultural norm.,https://meshb.nlm.nih.gov/record/ui?ui=D000079322
10,D063766,Pediatric Obesity,"BODY MASS INDEX in children (ages 2-12) and in adolescents (ages 13-18) that is grossly above the recommended cut-off for a specific age and sex. For infants less than 2 years of age, obesity is determined based on standard weight-for-length percentile measures.",https://meshb.nlm.nih.gov/record/ui?ui=D063766
11,D000079262,"Obesity, Maternal",BODY MASS INDEX in PREGNANT WOMEN that is excessively above the recommended cut-off.,https://meshb.nlm.nih.gov/record/ui?ui=D000079262
12,D000890,Anti-Infective Agents,"Generically, any agent that destroys microbes. However, usage of the term is increasingly being confined to agents that prevent or reduce the transmission of SEXUALLY TRANSMITTED DISEASES.",https://meshb.nlm.nih.gov/record/ui?ui=D000890
13,D023181,Antimicrobial Cationic Peptides,"Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane.",https://meshb.nlm.nih.gov/record/ui?ui=D023181
14,D004352,"Drug Resistance, Microbial","The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).",https://meshb.nlm.nih.gov/record/ui?ui=D004352
15,D000073602,Antimicrobial Stewardship,"Programs and guidelines for selecting optimal ANTI-INFECTIVE AGENTS regimens in an effort to maintain antibiotic efficacy, reduce CROSS INFECTION related to ANTIBIOTIC RESISTANCE while managing satisfactory clinical and economic outcomes.",https://meshb.nlm.nih.gov/record/ui?ui=D000073602
16,D009504,Neutrophils,Immature neutrophils.,https://meshb.nlm.nih.gov/record/ui?ui=D009504
17,D053146,Myeloblastin,A polymorphonuclear leukocyte-derived serine protease that degrades proteins such as ELASTIN; FIBRONECTIN; LAMININ; VITRONECTIN; and COLLAGEN. It is named for its ability to control myeloid cell growth and differentiation.,https://meshb.nlm.nih.gov/record/ui?ui=D053146
18,D019272,Leukocyte Elastase,"An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.",https://meshb.nlm.nih.gov/record/ui?ui=D019272
19,D018375,Neutrophil Activation,"The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonized particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil.",https://meshb.nlm.nih.gov/record/ui?ui=D018375
20,D020784,Matrix Metalloproteinase 8,"A member of the MATRIX METALLOPROTEINASES that cleaves triple-helical COLLAGEN types I, II, and III.",https://meshb.nlm.nih.gov/record/ui?ui=D020784
21,D008214,Lymphocytes,"White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS.",https://meshb.nlm.nih.gov/record/ui?ui=D008214
22,D018414,CD8-Positive T-Lymphocytes,"A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.",https://meshb.nlm.nih.gov/record/ui?ui=D018414
23,D008213,Lymphocyte Activation,"Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.",https://meshb.nlm.nih.gov/record/ui?ui=D008213
29,D005743,Gastrectomy,"Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)",https://meshb.nlm.nih.gov/record/ui?ui=D005743
30,D005774,Gastrostomy,Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression.,https://meshb.nlm.nih.gov/record/ui?ui=D005774
31,D004639,Emetics,"Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla.",https://meshb.nlm.nih.gov/record/ui?ui=D004639
32,D064420,Drug-Related Side Effects and Adverse Reactions,"Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.",https://meshb.nlm.nih.gov/record/ui?ui=D064420
34,D058186,Acute Kidney Injury,Conditions in which the function of KIDNEYS deteriorates suddenly in a matter of days or even hours. It is characterized by the sudden drop in GLOMERULAR FILTRATION RATE.,https://meshb.nlm.nih.gov/record/ui?ui=D058186
35,D017209,Apoptosis,Physiological forms of regulated cell death that occur during growth and development and tissue turnover.,https://meshb.nlm.nih.gov/record/ui?ui=D017209
36,D053478,Apoptosomes,Multimeric protein complexes formed in the CYTOSOL that play a role in the activation of APOPTOSIS. They can occur when MITOCHONDRIA become damaged due to cell stress and release CYTOCHROME C. Cytosolic cytochrome C associates with APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 to form the apoptosomal protein complex. The apoptosome signals apoptosis by binding to and activating specific INITIATOR CASPASES such as CASPASE 9.,https://meshb.nlm.nih.gov/record/ui?ui=D053478
37,D010587,Phagocytosis,"The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES).",https://meshb.nlm.nih.gov/record/ui?ui=D010587
38,D057899,Cytophagocytosis,The engulfment and degradation of cells by other cells.,https://meshb.nlm.nih.gov/record/ui?ui=D057899
39,D001343,Autophagy,Lysosomal degradation of ENDOPLASMIC RETICULUM by MACROAUTOPHAGY or MICROAUTOPHAGY.,https://meshb.nlm.nih.gov/record/ui?ui=D001343
40,D010586,Phagocytes,Cells that can carry out the process of PHAGOCYTOSIS.,https://meshb.nlm.nih.gov/record/ui?ui=D010586
42,D051017,Apoptosis Regulatory Proteins,A large group of proteins that control APOPTOSIS. This family of proteins includes many ONCOGENE PROTEINS as well as a wide variety of classes of INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS such as CASPASES.,https://meshb.nlm.nih.gov/record/ui?ui=D051017
43,D061026,Programmed Cell Death 1 Receptor,An inhibitory T-lymphocyte receptor that has specificity for CD274 ANTIGEN and PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN. Signaling by the receptor limits T cell proliferation and INTERFERON GAMMA synthesis. The receptor also may play an essential role in the regulatory pathway that induces PERIPHERAL TOLERANCE.,https://meshb.nlm.nih.gov/record/ui?ui=D061026
44,D000080549,Autophagic Cell Death,"A major activation of the autophagic pathway, characterized by massive accumulation of AUTOPHAGOSOMES and CELL DEATH.",https://meshb.nlm.nih.gov/record/ui?ui=D000080549
45,D061027,Programmed Cell Death 1 Ligand 2 Protein,"A costimulatory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 RECEPTOR. It is closely-related to CD274 antigen; however, its expression is restricted to DENDRITIC CELLS and activated MACROPHAGES.",https://meshb.nlm.nih.gov/record/ui?ui=D061027
46,D002477,Cells,"The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.",https://meshb.nlm.nih.gov/record/ui?ui=D002477
48,D058070,Asymptomatic Diseases,Diseases that do not exhibit symptoms.,https://meshb.nlm.nih.gov/record/ui?ui=D058070
49,D058345,Asymptomatic Infections,Infections that do not exhibit symptoms.,https://meshb.nlm.nih.gov/record/ui?ui=D058345
50,D008403,Mass Screening,Organized periodic procedures performed on large groups of people for the purpose of detecting disease.,https://meshb.nlm.nih.gov/record/ui?ui=D008403
51,D018583,Pliability,"The quality or state of being able to be bent or creased repeatedly. (From Webster, 3d ed)",https://meshb.nlm.nih.gov/record/ui?ui=D018583
52,D015203,Reproducibility of Results,Consistency of measurements in a test/procedure/assessment that is repeated over time.,https://meshb.nlm.nih.gov/record/ui?ui=D015203
53,D012463,Saliva,"The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin.",https://meshb.nlm.nih.gov/record/ui?ui=D012463
54,D008014,Lie Detection,Ascertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph.,https://meshb.nlm.nih.gov/record/ui?ui=D008014
55,D004972,Estrus Detection,Methods for recognizing the state of ESTRUS.,https://meshb.nlm.nih.gov/record/ui?ui=D004972
56,D010061,Ovulation Detection,"Method to determine the occurrence of OVULATION by direct or indirect means. Indirect methods examine the effects of PROGESTERONE on cervical mucus (CERVIX MUCUS), or basal body temperature. Direct ovulation detection, generally used in fertility treatment, involves analyses of circulating hormones in blood and ULTRASONOGRAPHY.",https://meshb.nlm.nih.gov/record/ui?ui=D010061
57,D045473,SARS Virus,"A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus.",https://meshb.nlm.nih.gov/record/ui?ui=D045473
58,D000071896,Medically Unexplained Symptoms,Persistent health symptoms which remain unexplained after a complete medical evaluation. A cluster of symptoms that consistently appear together but without a known cause are referred to as a MEDICALLY UNEXPLAINED SYNDROME (MUS).,https://meshb.nlm.nih.gov/record/ui?ui=D000071896
60,D013036,"Spasms, Infantile","An epileptic syndrome characterized by the triad of infantile spasms, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic (idiopathic) and symptomatic (secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.). (From Menkes, Textbook of Child Neurology, 5th ed, pp744-8)",https://meshb.nlm.nih.gov/record/ui?ui=D013036
63,D010361,Patients,"Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.",https://meshb.nlm.nih.gov/record/ui?ui=D010361
64,D028642,Mentally Ill Persons,"Persons with psychiatric illnesses or diseases, particularly psychotic and severe mood disorders.",https://meshb.nlm.nih.gov/record/ui?ui=D028642
65,D007297,Inpatients,"Persons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment.",https://meshb.nlm.nih.gov/record/ui?ui=D007297
67,D055088,Early Detection of Cancer,Procedures performed on people to identify those who have NEOPLASMS or PRENEOPLASTIC CONDITIONS.,https://meshb.nlm.nih.gov/record/ui?ui=D055088
68,D004353,"Drug Evaluation, Preclinical",Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications.,https://meshb.nlm.nih.gov/record/ui?ui=D004353
69,D005820,Genetic Testing,"Searching a population or individuals for persons possessing any of a set of certain gene mutations, genotypes, or karyotypes that: (1) are already associated with disease or predispose to disease; (2) may lead to disease in their descendants; or (3) produce other variations not known to be associated with disease. Genetic screening may be directed toward identifying phenotypic expression of genetic traits. It includes prenatal genetic screening.",https://meshb.nlm.nih.gov/record/ui?ui=D005820
70,D046148,Donor Selection,"The procedure established to evaluate the donated TISSUES or organs prior to selection for reuse. Donated specimens may be disqualified for reuse due to deteriorating conditions and risk factors, such as INFECTIONS, and HEREDITARY DISEASES.",https://meshb.nlm.nih.gov/record/ui?ui=D046148
71,D004358,Drug Therapy,The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.,https://meshb.nlm.nih.gov/record/ui?ui=D004358
72,D018380,Hematopoietic Stem Cell Transplantation,"Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.",https://meshb.nlm.nih.gov/record/ui?ui=D018380
73,D006412,Hematopoietic Stem Cells,Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood.,https://meshb.nlm.nih.gov/record/ui?ui=D006412
74,D033581,Stem Cell Transplantation,"The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.",https://meshb.nlm.nih.gov/record/ui?ui=D033581
75,D016465,Bone Marrow Purging,"Techniques for the removal of subpopulations of cells (usually residual tumor cells) from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents (laser photoirradiation or radioisotopes) and immunologic agents. Bone marrow purging is used in both autologous and allogeneic BONE MARROW TRANSPLANTATION.",https://meshb.nlm.nih.gov/record/ui?ui=D016465
76,D008279,Magnetic Resonance Imaging,Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.,https://meshb.nlm.nih.gov/record/ui?ui=D008279
77,D019028,"Magnetic Resonance Imaging, Cine","A type of imaging technique used primarily in the field of cardiology. By coordinating the fast gradient-echo MRI sequence with retrospective ECG-gating, numerous short time frames evenly spaced in the cardiac cycle are produced. These images are laced together in a cinematic display so that wall motion of the ventricles, valve motion, and blood flow patterns in the heart and great vessels can be visualized.",https://meshb.nlm.nih.gov/record/ui?ui=D019028
78,D053783,"Magnetic Resonance Imaging, Interventional",Minimally invasive procedures guided with the aid of magnetic resonance imaging to visualize tissue structures.,https://meshb.nlm.nih.gov/record/ui?ui=D053783
79,D009682,Magnetic Resonance Spectroscopy,"Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).",https://meshb.nlm.nih.gov/record/ui?ui=D009682
80,D018810,Magnetic Resonance Angiography,"A diagnostic technique for measuring the rate at which blood is delivered to tissue. In perfusion MRI, an exogenous contrast agent is usually injected to provide superior tissue contrast and easy delineation of perfusion abnormalities. Endogenous markers can also be used.",https://meshb.nlm.nih.gov/record/ui?ui=D018810
81,D009103,Multiple Sclerosis,"An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)",https://meshb.nlm.nih.gov/record/ui?ui=D009103
82,D020529,"Multiple Sclerosis, Relapsing-Remitting","The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)",https://meshb.nlm.nih.gov/record/ui?ui=D020529
83,D020528,"Multiple Sclerosis, Chronic Progressive","A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)",https://meshb.nlm.nih.gov/record/ui?ui=D020528
84,D007165,Immunosuppression,Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.,https://meshb.nlm.nih.gov/record/ui?ui=D007165
85,D001324,Autoantigens,Endogenous tissue constituents that have the ability to interact with AUTOANTIBODIES and cause an immune response.,https://meshb.nlm.nih.gov/record/ui?ui=D001324
86,D064592,Autografts,"Transplant comprised of an individual's own tissue, transferred from one part of the body to another.",https://meshb.nlm.nih.gov/record/ui?ui=D064592
87,D014182,"Transplantation, Autologous",Transplantation of an individual's own tissue from one site to another site.,https://meshb.nlm.nih.gov/record/ui?ui=D014182
89,D000077287,Levetiracetam,"A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.",https://meshb.nlm.nih.gov/record/ui?ui=D000077287
90,D015201,Meta-Analysis as Topic,"A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.",https://meshb.nlm.nih.gov/record/ui?ui=D015201
91,D000071076,Network Meta-Analysis,Meta-analysis of randomized trials in which estimates of comparative treatment effects are visualized and interpreted from a network of interventions that may or may not have been evaluated directly against each other. Common considerations in network meta-analysis include conceptual and statistical heterogeneity and incoherence.,https://meshb.nlm.nih.gov/record/ui?ui=D000071076
92,D010672,Phenytoin,"An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.",https://meshb.nlm.nih.gov/record/ui?ui=D010672
93,D008617,Mephenytoin,"An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.",https://meshb.nlm.nih.gov/record/ui?ui=D008617
94,D013226,Status Epilepticus,"A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)",https://meshb.nlm.nih.gov/record/ui?ui=D013226
95,D016896,Treatment Outcome,"Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.",https://meshb.nlm.nih.gov/record/ui?ui=D016896
96,D020377,Self Efficacy,"Cognitive mechanism based on expectations or beliefs about one's ability to perform actions necessary to produce a given effect. It is also a theoretical component of behavior change in various therapeutic treatments. (APA, Thesaurus of Psychological Index Terms, 1994)",https://meshb.nlm.nih.gov/record/ui?ui=D020377
97,D012449,Safety,"Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property.",https://meshb.nlm.nih.gov/record/ui?ui=D012449
98,D059022,Food Safety,Activities involved in ensuring the safety of FOOD including avoidance of bacterial and other contamination.,https://meshb.nlm.nih.gov/record/ui?ui=D059022
99,D061214,Patient Safety,"Efforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers.",https://meshb.nlm.nih.gov/record/ui?ui=D061214
100,D005135,Eye Protective Devices,"Personal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation.",https://meshb.nlm.nih.gov/record/ui?ui=D005135
101,D062067,Chemical Safety,Measures and or processes implemented to reduce and or eliminate hazards associated with chemicals.,https://meshb.nlm.nih.gov/record/ui?ui=D062067
103,D013812,Therapeutics,Procedures concerned with the remedial treatment or prevention of diseases.,https://meshb.nlm.nih.gov/record/ui?ui=D013812
104,D019233,Retreatment,"The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.",https://meshb.nlm.nih.gov/record/ui?ui=D019233
105,D015199,Extracorporeal Membrane Oxygenation,"Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of SMOKE INHALATION INJURY; RESPIRATORY FAILURE; and CARDIAC FAILURE.",https://meshb.nlm.nih.gov/record/ui?ui=D015199
106,D017048,Health Care Costs,"The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost.",https://meshb.nlm.nih.gov/record/ui?ui=D017048
107,D018508,Water Purification,Processes used to make water more acceptable for a desired end-use,https://meshb.nlm.nih.gov/record/ui?ui=D018508
111,D016032,Randomized Controlled Trials as Topic,"Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.",https://meshb.nlm.nih.gov/record/ui?ui=D016032
112,D065228,Non-Randomized Controlled Trials as Topic,"Works about a study where participants are assigned to a treatment, procedure, or intervention by methods that are not random. Non-randomized clinical trials are sometimes referred to as quasi-experimental clinical trials or non-equivalent control group designs.",https://meshb.nlm.nih.gov/record/ui?ui=D065228
113,D015850,Interleukin-6,A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.,https://meshb.nlm.nih.gov/record/ui?ui=D015850
114,D053633,"Receptor, Interferon alpha-beta",The full-length variant of the IFNAR2 chain.,https://meshb.nlm.nih.gov/record/ui?ui=D053633
115,D000077190,Interferon alpha-2,A recombinant form of interferon alpha-2. This variant has LYSINE at position 23 and HISTIDINE at position 34.,https://meshb.nlm.nih.gov/record/ui?ui=D000077190
116,D016898,Interferon-alpha,"One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.",https://meshb.nlm.nih.gov/record/ui?ui=D016898
117,D000068576,Interferon beta-1b,A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.,https://meshb.nlm.nih.gov/record/ui?ui=D000068576
118,D007443,Intussusception,"A form of intestinal obstruction caused by the PROLAPSE of a part of the intestine into the adjoining intestinal lumen. There are four types: colic, involving segments of the LARGE INTESTINE; enteric, involving only the SMALL INTESTINE; ileocecal, in which the ILEOCECAL VALVE prolapses into the CECUM, drawing the ILEUM along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the COLON.",https://meshb.nlm.nih.gov/record/ui?ui=D007443
119,D012401,Rotavirus,A strain of the species Rotavirus A.,https://meshb.nlm.nih.gov/record/ui?ui=D012401
120,D012400,Rotavirus Infections,"Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.",https://meshb.nlm.nih.gov/record/ui?ui=D012400
121,D022243,Rotavirus Vaccines,Vaccines or candidate vaccines used to prevent infection with ROTAVIRUS.,https://meshb.nlm.nih.gov/record/ui?ui=D022243
122,D014611,Vaccination,Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.,https://meshb.nlm.nih.gov/record/ui?ui=D014611
123,D032541,Mass Vaccination,Administration of a vaccine to large populations in order to elicit IMMUNITY.,https://meshb.nlm.nih.gov/record/ui?ui=D032541
124,D017589,Immunization Programs,"Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international.",https://meshb.nlm.nih.gov/record/ui?ui=D017589
125,D007117,"Immunization, Secondary",Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.,https://meshb.nlm.nih.gov/record/ui?ui=D007117
126,D017778,"Vaccines, Combined",Two or more vaccines in a single dosage form.,https://meshb.nlm.nih.gov/record/ui?ui=D017778
127,D057832,Watchful Waiting,"Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness. (Driffield T, Smith PC Med Decis Making. 2007 Mar-Apr;27(2):178-88)",https://meshb.nlm.nih.gov/record/ui?ui=D057832
128,D055877,Biosurveillance,"Monitoring of information sources of potential value in detecting an emerging epidemic, whether naturally occurring or the result of bioterrorism.",https://meshb.nlm.nih.gov/record/ui?ui=D055877
129,D000080030,Legal Epidemiology,"Systematic, scientific collection and analysis of laws of public health significance.",https://meshb.nlm.nih.gov/record/ui?ui=D000080030
130,D018571,Sentinel Surveillance,"Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in a larger population. (From Last, Dictionary of Epidemiology, 2d ed)",https://meshb.nlm.nih.gov/record/ui?ui=D018571
131,D011159,Population Surveillance,"Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.",https://meshb.nlm.nih.gov/record/ui?ui=D011159
132,D002648,Child,"A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.",https://meshb.nlm.nih.gov/record/ui?ui=D002648
133,D000073921,"Child, Foster","Individual who is unable to live safely with his or her family, usually due to abuse or neglect in the family home.",https://meshb.nlm.nih.gov/record/ui?ui=D000073921
134,D032721,Adult Children,Children who have reached maturity or the legal age of majority.,https://meshb.nlm.nih.gov/record/ui?ui=D032721
135,D018453,Homeless Youth,Runaway and homeless children and adolescents living on the streets of cities and having no fixed place of residence.,https://meshb.nlm.nih.gov/record/ui?ui=D018453
136,D009863,Only Child,Child who has no siblings.,https://meshb.nlm.nih.gov/record/ui?ui=D009863
138,D012926,"Social Control, Formal",Exercise of the authority to restrict or supervise a practice or the conduct of a facility or organization. (AN: not to be used for gene regulation or any biological practices),https://meshb.nlm.nih.gov/record/ui?ui=D012926
139,D021081,Chronobiology Disorders,Disruptions of the rhythmic cycle of bodily functions or activities.,https://meshb.nlm.nih.gov/record/ui?ui=D021081
140,D018417,Th1 Cells,"A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.",https://meshb.nlm.nih.gov/record/ui?ui=D018417
141,D018418,Th2 Cells,A subset of helper-inducer T-lymphocytes which synthesize and secrete the INTERLEUKINS IL-4; IL-5; IL-6; and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.,https://meshb.nlm.nih.gov/record/ui?ui=D018418
142,D006377,"T-Lymphocytes, Helper-Inducer","Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions.",https://meshb.nlm.nih.gov/record/ui?ui=D006377
143,D007858,Learning,Enhancement strategies to improve duration and retention of information.,https://meshb.nlm.nih.gov/record/ui?ui=D007858
144,D018794,Problem-Based Learning,Instructional use of examples or cases to teach using problem-solving skills and critical thinking.,https://meshb.nlm.nih.gov/record/ui?ui=D018794
145,D012691,Serial Learning,Learning to make a series of responses in exact order.,https://meshb.nlm.nih.gov/record/ui?ui=D012691
146,D000067570,Social Learning,The concept of new knowledge acquisition through observation and interaction with others.,https://meshb.nlm.nih.gov/record/ui?ui=D000067570
147,D065853,Spatial Learning,A process through which individuals encode information about their environmental CUES to facilitate SPATIAL NAVIGATION.,https://meshb.nlm.nih.gov/record/ui?ui=D065853
148,D008661,"Metabolism, Inborn Errors",Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.,https://meshb.nlm.nih.gov/record/ui?ui=D008661
149,D007109,Immunity,Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.,https://meshb.nlm.nih.gov/record/ui?ui=D007109
150,D057865,Plant Immunity,Specific signaling cascades set in motion to defend against or repel pathogens.,https://meshb.nlm.nih.gov/record/ui?ui=D057865
151,D032521,"Immunity, Herd","The non-susceptibility to infection of a large group of individuals in a population. A variety of factors can be responsible for herd immunity and this gives rise to the different definitions used in the literature. Most commonly, herd immunity refers to the case when, if most of the population is immune, infection of a single individual will not cause an epidemic. Also, in such immunized populations, susceptible individuals are not likely to become infected. Herd immunity can also refer to the case when unprotected individuals fail to contract a disease because the infecting organism has been banished from the population.",https://meshb.nlm.nih.gov/record/ui?ui=D032521
152,D007113,"Immunity, Innate","The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.",https://meshb.nlm.nih.gov/record/ui?ui=D007113
153,D018928,"Immunity, Mucosal","Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.",https://meshb.nlm.nih.gov/record/ui?ui=D018928
